On Monday, Tenet Healthcare got a positive adjustment to its Relative Strength (RS) Rating, from 63 to 76.
Can You Really Time The Stock Market?
IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains typically have an RS Rating of over 80 in the early stages of their moves. See if Tenet Healthcare can continue to show renewed price strength and clear that threshold.
Tenet Healthcare is not currently offering a proper buying opportunity. See if the stock goes on to build a promising consolidation that could launch a new move.
In terms of top and bottom line numbers, Tenet Healthcare has posted rising EPS growth in each of the last two reports. Top line growth has also risen during the same period.
Tenet Healthcare holds the No. 1 rank among its peers in the Medical-Hospitals industry group. Nutex Health and Universal Health Cl B are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
